challenges moving from sciences to implementation in china
DESCRIPTION
Challenges Moving from Sciences to Implementation in China. Zunyou Wu National Center for AIDS/STD Control and Prevention Chinese Center for Disease Control and Prevention. Goal. By 2015 : The number of people living with HIV/AIDS be controlled no more than 1,200,000 . - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Challenges Moving from Sciences to Implementation in China](https://reader036.vdocuments.site/reader036/viewer/2022062305/56815b31550346895dc8fed4/html5/thumbnails/1.jpg)
Challenges Moving from Sciences to Implementation in China
Zunyou Wu
National Center for AIDS/STD Control and PreventionChinese Center for Disease Control and Prevention
![Page 2: Challenges Moving from Sciences to Implementation in China](https://reader036.vdocuments.site/reader036/viewer/2022062305/56815b31550346895dc8fed4/html5/thumbnails/2.jpg)
Goal
By 2015:– The number of people living with HIV/AIDS be
controlled no more than 1,200,000.
• New HIV infection 25%;
• AIDS Mortality 30%。
To achieve these targets,
We need implementation sciences
![Page 3: Challenges Moving from Sciences to Implementation in China](https://reader036.vdocuments.site/reader036/viewer/2022062305/56815b31550346895dc8fed4/html5/thumbnails/3.jpg)
Can incidence decline but annual reported HIV cases
continually increase?
HIV AIDS Death
Cases
HIV/AIDS reported in China during 1985-2011
Year
2005 2007 2009 2011 2013 2015
New HIV 70,000 50,000 48,000 48,000 36,000
![Page 4: Challenges Moving from Sciences to Implementation in China](https://reader036.vdocuments.site/reader036/viewer/2022062305/56815b31550346895dc8fed4/html5/thumbnails/4.jpg)
Further have mortality DROP We need Implementation Sciences
Since ART launch in 2002, AIDS mortality dropped
significantly
![Page 5: Challenges Moving from Sciences to Implementation in China](https://reader036.vdocuments.site/reader036/viewer/2022062305/56815b31550346895dc8fed4/html5/thumbnails/5.jpg)
• 5
Annual Reported AIDS Mortality
Q1: Why ART , but Mortality ?Q2: When and how to get Mortality ? ???
???
Reported death same year
Reported death previous year
80% Deaths
without ART
![Page 6: Challenges Moving from Sciences to Implementation in China](https://reader036.vdocuments.site/reader036/viewer/2022062305/56815b31550346895dc8fed4/html5/thumbnails/6.jpg)
Late Diagnosis Still an Issue
year Newly Identified
AIDS at 1st test
Proportion of late( %)
2008 56362 10790 19.1
2009 61626 13433 21.8
2010 64338 16089 25.0
2011 74517 20760 27.6
6
![Page 7: Challenges Moving from Sciences to Implementation in China](https://reader036.vdocuments.site/reader036/viewer/2022062305/56815b31550346895dc8fed4/html5/thumbnails/7.jpg)
Losses along the Continuum of HIV Care
7
25
20
15
10
5
ScreenedHIV-Positive
ConfirmedHIV-Positive
NotifiedHIV-Positive
ReceivedCD4 Test
ReceivedART
ReceivedVL Test
0
Num
ber o
f ind
ivid
uals
(1
,000
)
22,825(100%)
9,091(40%) 7,754
(34%)4,830(21%) 2,691
(12%) 732(8%)
![Page 8: Challenges Moving from Sciences to Implementation in China](https://reader036.vdocuments.site/reader036/viewer/2022062305/56815b31550346895dc8fed4/html5/thumbnails/8.jpg)
8
Use New Strategies
• TEST as Prevention
• TREATMENT as Prevention
New vs. existing strategies
Continue Use Traditional ones
Education
Condom promotion
Harm reduction
Counseling
STD management
![Page 9: Challenges Moving from Sciences to Implementation in China](https://reader036.vdocuments.site/reader036/viewer/2022062305/56815b31550346895dc8fed4/html5/thumbnails/9.jpg)
9
Who Working with?
Prevention by Working with
• HIV Positives
• HIV Negatives
![Page 10: Challenges Moving from Sciences to Implementation in China](https://reader036.vdocuments.site/reader036/viewer/2022062305/56815b31550346895dc8fed4/html5/thumbnails/10.jpg)
ART vs. PrEP
Population size
Population size
ARTHIV +
PrEPAt risk
![Page 11: Challenges Moving from Sciences to Implementation in China](https://reader036.vdocuments.site/reader036/viewer/2022062305/56815b31550346895dc8fed4/html5/thumbnails/11.jpg)
11
New strategies
Strategies Implementation
Testing
Treatment as Prevention
PrEP ?
Male circumcision ?
Microbicides ?
![Page 12: Challenges Moving from Sciences to Implementation in China](https://reader036.vdocuments.site/reader036/viewer/2022062305/56815b31550346895dc8fed4/html5/thumbnails/12.jpg)
12
Conclusion
• Fully Implement Existing Approved Strategies
• Adopt new strategies positively